Rhenman & Partners Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $8.1M | Sell |
|
|||||
|
2022
Q2 | $25.9M | Sell |
|
|||||
|
2022
Q1 | $35.3M | Sell |
|
|||||
|
2021
Q4 | $46M | Sell |
|
|||||
|
2021
Q3 | $51.5M | Sell |
|
|||||
|
2021
Q2 | $49.2M | Sell |
|
|||||
|
2021
Q1 | $54.8M | Sell |
|
|||||
|
2020
Q4 | $43.9M | Sell |
|
|||||
|
2020
Q3 | $54M | Sell |
|
|||||
|
2020
Q2 | $41.7M | Sell |
|
|||||
|
2020
Q1 | $29.6M | Buy |
|
|||||
|
2019
Q4 | $28.1M | Sell |
|
|||||
|
2019
Q3 | $27.9M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $24.8M | Sell |
|
|||||
|
2018
Q4 | $18.5M | Buy |
|
|||||
|
2018
Q3 | $18M | Sell |
|
|||||
|
2018
Q2 | $27M | Sell |
|
|||||
|
2018
Q1 | $28.5M | Buy |
|
|||||
|
2017
Q4 | $28.5M | Sell |
|
|||||
|
2017
Q3 | $38.1M | Buy |
|
|||||
|
2017
Q2 | $28.8M | Buy |
|
|||||
|
2017
Q1 | $25.9M | Buy |
|
|||||
|
2016
Q4 | $11.3M | Buy |
|
|||||
|
2016
Q3 | $6.62M | Sell |
|
|||||
|
2016
Q2 | $6.09M | Buy |
|
|||||
|
2016
Q1 | $3.31M | Buy |
|
|||||
|
2015
Q4 | $3.16M | Buy |
|